Forte Medical case study within Imperial College Innovation paper

Commissioned by Lord Sainsbury and authored by Professor James Moore and Yunus Kutlu, Imperial College has published a report on innovation adoption in the UK and wh

at prevents successful adoption of impactful innovation. Forte Medical features as the only case study and outlines issues with silo systems, a disconnect between procurement and fincance all topped off with vested interests from labs and leadership.

The Peezy Midstream case study outlines how adoption of preventative devices and practice are resisted, leading to missed opportunities for improved patient health, prompt diagnoses, prevention and huge cost savings across the patient pathway.

Read all about it here. – see Page 29 and Appendix 2

Imperial Business School: a MedTech to Market Journey

Giovanna’s annual talk to the Imperial Business School took place last week; here we share the presentation Deck. Had she known in 2002 what she knows now, it would have taken a third of the time to create three specimen collection products and a springboard to global reach. She and Dr Vincent Forte are beyond proud of what they have achieved. 202210_ForteMedical_HealthTech_Commercialisation_Journey

US Partnership Deal With Owen Mumford Announced

The partnership between Forte Medical and Owen Mumford USA was launched today at the OCTANe Medical Innovation Technology Forum (MTIF) at Newport Beach, CA 28-29 October 2019. 

Introducing Peezy Midstream to the USA has long been an ambition of Forte Medical. Our disruptive and innovative MedTech called for a partner with experience, knowledge and a savvy mindset. We found that partner in Atlanta-based Owen Mumford USA whose reach covers the USA and Canada and is managed by Travis Shaw.

Owen Mumford has been at the forefront of medical device innovation for over 65 years, creating solutions that improve the delivery of healthcare and home health treatments for people around the world. Their products span devices that make blood testing more comfortable to solutions that make it easier to administer life-saving medication.

Owen Mumford’s experience in medical devices began in the 1950s when founders Ivan Owen and John Mumford established the company. The company have direct sales offices and a network of distribution partners serving customers in over 60 countries, and employ over 800 people across the Americas, Europe and Asia.  

“Owen Mumford USA is delighted to partner Forte Medical in North America and Canada,” says Travis Shaw. “Our team looks forward to expanding our mutual synergies. Research indicates that Peezy Midstream can add significant clinical and cost value to healthcare providers, a true win-win for all parties.”
 
Thanks to the Greater Irvine Chamber of Commerce for making this possible.

Forte Medical Review

A Year In Review – 2018

  • New evidence showing a 70% reduction in false positive dipped specimens
  • Extended uptake by the NHS
  • Investment including a JV to create a Smart Peezy
  • Sheena Byrom joining our Advisory Panel
  • Being recognised in the Sunday Times 2018 Maserati 100 list that celebrate British entrepreneurship

These have been a few of our highlights for 2018 – to read more, please click here

Forte Medical UCI conference

Attending the Greater Irvine Chamber’s 2018 Life Sciences

Giovanna Forte, CEO was delighted to be one of 10 British executives to make their way to UC Irvine (UCI) for the Greater Irvine Chamber’s 2018 Life Science Showcase event.

In collaboration with UCI Applied Innovation, the Greater Irvine Chamber hosted UK owned life science companies to position Southern California and UCI as a strong global brand for innovation and entrepreneurship. Applied Innovation worked closely with the chamber to promote industry cluster growth in the region.

Click here to read more about the event

Texas MedTech Mission Create Demand for British Goods

Paul Benton, International Director at the ABHI shares our story as to how we entered the US marketplace

Appointed sales and distribution partners, dedicated warehouse facilities and new US customers are just some of the outcomes from the UK MedTech missions to Texas.  Read more

ABHI Innovation Hub Established at Dell Medical School, Texas

As a regular participant of the ABHI Trade Missions to Texas, we are delighted to be part of this exciting development….

The Association of British Healthcare Industries (ABHI) and the Dell Medical School at The University of Texas at Austin are delighted to announce the establishment of the “ABHI Innovation Hub”.

The creation of the Hub, a first for ABHI, will offer UK companies the opportunity to locate themselves at a world-class facility and develop their US business within an ecosystem of clinicians, investors and mentors. It offers companies a compelling office location, providing them the infrastructure to focus on accelerating market access in Texas and beyond.

The Hub will be located within Dell Med’s Health CoLab, a new initiative that provides space and creates connections for start-up companies that share the school’s mission to create healthier communities, starting in Austin and the surrounding area. The Health CoLab directly supports the school, seeking out innovation that promotes health, enhances medical services, increases care resources and access for people in this community in ways that can be scaled to other communities.

“The ABHI Innovation Hub at Dell Medical School will offer UK companies a unique opportunity to collaborate in a truly world class facility,” said Phil Kennedy, Chairman of the ABHI. “The Hub will support promising medical technology innovation whilst looking to develop value based healthcare for the benefit of patients in Texas, throughout the US and at home in the UK.”

The Dell Medical School has a strong focus on supporting health entrepreneurs and businesses. In addition to the CoLab, companies that base themselves in the Innovation Hub will be able to participate in the ‘Texas Health Catalyst,’ a programme designed by the Dell Medical School to foster health research and advance innovation.

“We are very excited to be working with ABHI to strengthen ties between the UK and Austin across a variety of health and technology areas,” said Ruben Rathnasingham, Assistant Dean for Health Product Innovation at Dell Medical School. “We look forward to working with the ABHI, its members and the UK going forward.”

The partnership also extends support to Texas-based companies that are looking to understand and enter the UK healthcare market. Through ABHI’s International Membership scheme, companies looking to introduce innovative medical technology (MedTech) to the UK will be offered insight and market-access knowledge, as well as assistance from a number of partner organisations, including the UK’s Department of International Trade.

“Through this collaboration, companies will be closer to a range of innovation initiatives that we have created and are continuing to create at Dell Med,” said Mellie Price, the school’s Executive Director of Commercialization. “They will find themselves in a rich, creative environment.”

Texas: land of clinical and procurement collaboration

Forte Medical is just back from a successful and educational ABHI MedTech Mission to Texas.

The most valuable intelligence we gleaned was the way in which Clinical and Procurement leadership teams collaborate; this means a more joined up introduction of innovation that will deliver clinical and economic effiencies.

Read more about our visit and who we met, on LinkedIn.

Exporting healthcare innovation: an interview

 

Interesting specimens: saving healthcare budgets by exporting healthcare innovation and universal diligence.

LinkedInPicOnline business magazine Womanthology interviewed Forte Medical CEO Giovanna Forte about specimen collection as an overlooked area of medicine, solving problems and exporting to the USA. Read the interview.